Novel vaccines for use against -hemolytic Streptococcus colonization or infection are disclosed. The vaccines contain an immunogenic amount of a variant of streptococcal C5a peptidase (SCP). Also disclosed is a method of protecting a susceptible mammal against -hemolytic Streptococcus colonization or infection by administering such a vaccine. Enzymatically inactive SCP, and polynucleotides encoding these SCP proteins are further disclosed.

 
Web www.patentalert.com

< Process for protein extraction

< Prolonged release microspheres for injectable administration

> Intravaginal drug delivery devices for the administration of an antimicrobial agent

> Pro-micelle pharmaceutical compositions

~ 00212